Semiconductors × Precision Medicine: KAiTA Launches a Comprehensive Initiative to Connect AI Healthcare Computing Power with Global Capital
Semiconductors × Precision Medicine: KAiTA Launches a Comprehensive Initiative to Connect AI Healthcare Computing Power with Global Capital
Keiyo President Chen Chen-hsing Meets with Diet Member Keizo Takemi to Discuss the KAiTA Healthcare AI Vision
[Tokyo, Japan] January 7, 2026
Following the official launch of the Kumamoto AI Technology Arena (hereinafter referred to as the KAiTA Project) in Kumamoto, Chen Chen-hsing, President and Representative Director of Keiyo Co., Ltd., recently held an in-depth meeting with Keizo Takemi, former Minister of Health, Labour and Welfare of Japan and current member of the House of Councillors of the Liberal Democratic Party.
During the meeting, President Chen shared his observations on the emerging trend of AI-driven digital transformation in healthcare. The two sides also held extensive discussions on how regenerative medicine and Japan’s biopharmaceutical industry can leverage international capital to accelerate development. Diet Member Takemi expressed strong support for the KAiTA Project’s overall direction and strategic positioning. Following the meeting, he reaffirmed his support and indicated that he would provide assistance as needed to help advance the initiative.
Caption: (Left) Chen Chen-hsing, Representative Director of Keiyo Co., Ltd.; (Right) Keizo Takemi, former Minister of Health, Labour and Welfare of Japan. The two posed for a commemorative photograph following their meeting on January 7, 2026.
KAiTA’s Strategic Positioning: From Semiconductor Manufacturing to Healthcare Applications
President Chen provided a detailed overview of KAiTA’s broader positioning within the AI ecosystem, emphasizing that Kumamoto is not only a major semiconductor manufacturing hub but also has the potential to become a “computing hub for AI healthcare and regenerative medicine.” Located approximately three minutes by car from TSMC’s Japan Advanced Semiconductor Manufacturing (JASM) facility, KAiTA benefits from a strategic geographic advantage that could enable the project to rapidly access advanced semiconductor technologies and infrastructure, providing a robust foundation for computationally intensive healthcare big-data processing and AI model development.
🚀 Key Initiative: Building an Intelligent Healthcare Computing Hub
- ● High-Performance Computing Support: Leverage the project’s data center infrastructure to accelerate the development of AI-powered medical imaging and precision medicine applications.
- ● Cross-Border Technology and Capital Validation: Attract Taiwanese and Japanese biotechnology startups to the project, combine international capital and resources, and establish an integrated validation environment spanning semiconductor technologies through clinical applications.
- ● Talent and Resource Integration: Leverage Keiyo’s resources and local capabilities in Kumamoto to deepen exchanges and collaboration among healthcare and AI professionals in Taiwan and Japan.
The meeting marks a new phase in the development of the “Silicon Valley of Kumamoto,” expanding from hardware manufacturing into high-value healthcare applications. It also highlights the potential for Japan’s regenerative medicine and biopharmaceutical industries to strengthen their research and development capabilities and international competitiveness by integrating international capital and global resources. President Chen stated that, with continued policy support, Keiyo will accelerate efforts to position KAiTA as a key hub connecting the technology and healthcare industry chains of Taiwan and Japan, with the long-term goal of leveraging smart technologies to create meaningful social impact.